Several studies focused on the PI3K/Akt pathway for chemo-resistance in ovarian cancers and showed that Cisplatin could upregulate p53 and induce apoptosis in these cancer cells after expression of dominant negative AKT, which suggested that cisplatin-mediated p53 upregulation was opposed by AKT. Here, AKT1 is linked to ovarian cancer.